3 research outputs found
Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging
Nanotechnology
provides a promising platform for drug-delivery
in medicine. Nanostructured materials can be designed with desired
superparamagnetic or fluorescent properties in conjunction with biochemically
functionalized moieties (i.e., antibodies, peptides, and small molecules)
to actively bind to target sites. These multifunctional properties
make them suitable agents for multimodal imaging, diagnosis, and therapy.
Perfluorohexane nanoemulsions (PFH-NEs) are novel drug-delivery vehicles
and contrast agents for ultrasound and photoacoustic imaging of cancer <i>in vivo</i>, offering higher spatial resolution and deeper penetration
of tissue when compared to conventional optical techniques. Compared
to other theranostic agents, our PFH-NEs are one of the smallest of
their kind (<100 nm), exhibit
minimal aggregation, long-term stability at physiological conditions,
and provide a noninvasive cancer imaging and therapy alternative for
patients. Here, we show, using high-resolution imaging and correlative
techniques, that our PFH-NEs, when in tandem with silica-coated gold
nanoparticles (scAuNPs), can be used as a drug-loaded therapeutic
via endocytosis and as a multimodal imaging agent for photoacoustic,
ultrasound, and fluorescence imaging of tumor growth
Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging
Nanotechnology
provides a promising platform for drug-delivery
in medicine. Nanostructured materials can be designed with desired
superparamagnetic or fluorescent properties in conjunction with biochemically
functionalized moieties (i.e., antibodies, peptides, and small molecules)
to actively bind to target sites. These multifunctional properties
make them suitable agents for multimodal imaging, diagnosis, and therapy.
Perfluorohexane nanoemulsions (PFH-NEs) are novel drug-delivery vehicles
and contrast agents for ultrasound and photoacoustic imaging of cancer <i>in vivo</i>, offering higher spatial resolution and deeper penetration
of tissue when compared to conventional optical techniques. Compared
to other theranostic agents, our PFH-NEs are one of the smallest of
their kind (<100 nm), exhibit
minimal aggregation, long-term stability at physiological conditions,
and provide a noninvasive cancer imaging and therapy alternative for
patients. Here, we show, using high-resolution imaging and correlative
techniques, that our PFH-NEs, when in tandem with silica-coated gold
nanoparticles (scAuNPs), can be used as a drug-loaded therapeutic
via endocytosis and as a multimodal imaging agent for photoacoustic,
ultrasound, and fluorescence imaging of tumor growth
Single-Molecule Analysis of the Supramolecular Organization of the M<sub>2</sub> Muscarinic Receptor and the GĪ±<sub>i1</sub> Protein
G protein-coupled receptors constitute
the largest family of transmembrane
signaling proteins and the largest pool of drug targets, yet their
mechanism of action remains obscure. That uncertainty relates to unresolved
questions regarding the supramolecular nature of the signaling complex
formed by receptor and G protein. We therefore have characterized
the oligomeric status of eGFP-tagged M<sub>2</sub> muscarinic receptor
(M<sub>2</sub>R) and G<sub>i1</sub> by single-particle photobleaching
of immobilized complexes. The method was calibrated with multiplexed
controls comprising 1ā4 copies of fused eGFP. The photobleaching
patterns of eGFP-M<sub>2</sub>R were indicative of a tetramer and
unaffected by muscarinic ligands; those of eGFP-G<sub>i1</sub> were
indicative of a hexamer and unaffected by GTPĪ³S. A complex of
M<sub>2</sub>R and G<sub>i1</sub> was tetrameric in both, and activation
by a full agonist plus GTPĪ³S reduced the oligomeric size of
G<sub>i1</sub> without affecting that of the receptor. A similar reduction
was observed upon activation of eGFP-GĪ±<sub>i1</sub> by the
receptor-mimic mastoparan plus GTPĪ³S, and constitutively active
eGFP-GĪ±<sub>i1</sub> was predominantly dimeric. The oligomeric
nature of G<sub>i1</sub> in live CHO cells was demonstrated by means
of FoĢrster resonance energy transfer and dual-color fluorescence
correlation spectroscopy in studies with eGFP- and mCherry-labeled
GĪ±<sub>i1</sub>; stochastic FRET was ruled out by means of non-interacting
pairs. These results suggest that the complex between M<sub>2</sub>R and holo-G<sub>i1</sub> is an octamer comprising four copies of
each, and that activation is accompanied by a decrease in the oligomeric
size of G<sub>i1</sub>. The structural feasibility of such a complex
was demonstrated in molecular dynamics simulations